Research has linked GLP-1 medications to lower risks of cardiovascular disease, kidney disease, and even some neurodegenerative disorders
When used thoughtfully, weight loss injections can support healthier outcomes while minimizing risks
10.1186/s12933-020-01197-z 13
GLP-1 agonists (Table 1) activate GLP-1 receptors located in multiple organs, including the pancreas, gastrointestinal tract, and brain, which potentiate glucose-stimulated insulin secretion and assist in diabetic control [4,5,6]
But like all drugs, it can have potential side effects, he said
Its likely to still be there at the end of the year, but by the time the final sales figures for 2024 are tallied up, Novo Nordisks semaglutide is set to sit in second place